ENLIVEN THERAPEUTICS, INC.

Press Releases Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2024 BST			5-day change	1st Jan Change
21.04 ^USD	+2.78%		-4.45%	+52.02%

06-11	Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target	MT
05-29	Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Enliven Therapeutics to Present at Two Upcoming Investor Conferences	05-29	AQ
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update	05-14	AQ
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia	04-11	AQ
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors	04-09	AQ
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024	03-28	AQ
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates	03-19	AQ
Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update	03-14	AQ
Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference	02-27	AQ
Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update	11-09	AQ
Enliven Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress	10/08/23	AQ
Enliven Therapeutics : Material Agreement - Form 8-K	26/06/23	PU
Enliven Therapeutics : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K	23/06/23	PU
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies	16/03/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer